The Clinical Use of Stress Echocardiography in Non-Ischaemic Heart Disease: Recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography

详细信息    查看全文

• 作者：Patrizio Lancellotti ; MD ; PhD ; FESC (Chair)^a ; ^b ; ^{plancellotti@chu.ulg.ac.be} ; Patricia A. Pellikka ; MD ; FASE (Co-Chair)^c ; Werner Budts ; MD ; PhD^d ; Farooq A. Chaudhry ; MD ; FASE^e ; Erwan Donal ; MD ; PhD ; FESC^f ; Raluca Dulgheru ; MD^a ; Thor Edvardsen ; MD ; PhD ; FESC^g ; Madalina Garbi ; MD ; MA^h ; Jong Won Ha ; MD ; PhD ; FESCⁱ ; Garvan C. Kane ; MD ; PhD ; FASE^c ; Joe Kreeger ; ACS ; RCCS ; RDCS ; FASE^j ; Luc Mertens ; MD ; PhD ; FASE^k ; Philippe Pibarot ; DVM ; PhD ; FASE ; FESC^l ; Eugenio Picano ; MD ; PhD^m ; Thomas Ryan ; MD ; FASEⁿ ; Jeane M. Tsutsui ; MD ; PhD^o ; Albert Varga ; MD ; PhD ; FESC^p
• 关键词：Cardiomyopathy ; Congenital heart disease ; Heart failure ; Pulmonary hypertension ; Stress echocardiography ; Stress test ; Valvular heart disease
• 刊名：Journal of the American Society of Echocardiography
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：30
• 期：2
• 页码：101-138
• 全文大小：8191 K
• 卷排序：30

文摘

A unique and highly versatile technique, stress echocardiography (SE) is increasingly recognized for its utility in the evaluation of non-ischaemic heart disease. SE allows for simultaneous assessment of myocardial function and haemodynamics under physiological or pharmacological conditions. Due to its diagnostic and prognostic value, SE has become widely implemented to assess various conditions other than ischaemic heart disease. It has thus become essential to establish guidance for its applications and performance in the area of non-ischaemic heart disease. This paper summarizes these recommendations.